Oncology 72 (1-2): 51-7, 2007.[PUBMED Abstract] Degardin M, Bonneterre J, Hecquet B, et al.: Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer.
Ann Oncol 5 (5): 423-6, 1994.[PUBMED Abstract] Carmichael J, Walling J: Advanced breast cancer: investigational role of gemcitabine.
Eur J Cancer 33 (Suppl 1): S27-30, 1997.[PUBMED Abstract] Vahdat LT, Pruitt B, Fabian CJ, et al.: Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
J Clin Oncol 27 (18): 2954-61, 2009.[PUBMED Abstract] Cortes J, O'Shaughnessy J, Loesch D, et al.: Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.